dendritic cell tumor fusion vaccine
Vaccineexperimental
Clinical trial activity
11 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
8
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2000 (NCT00626860)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous dendritic cell-tumor fusion vaccine
- dc/tumor fusion vaccine
- dendritic cell/myeloma fusions
- dendritic cell tumor fusion
- dendritic cell tumor fusion vaccine
- dendritic cell/tumor fusion vaccine
- regulatory donor-derived dendritic cell infusion
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03164265 | Phase 1/Phase 2 (Phase 2) | May 1, 2017 | University of Pittsburgh |
| NCT02728102 | Phase 2 | Jul 1, 2016 | Blood and Marrow Transplant Clinical Trials Network, Center for International Blood and Marrow Transplant Research, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), National Marrow Donor Program |
| NCT01239875 | N/A | Nov 1, 2010 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00622401 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2009 | Department of Defense, Harvard University, National Cancer Institute (NCI) |
| NCT00799110 | Phase 2 | Aug 1, 2008 | Harvard University, National Cancer Institute (NCI) |
| NCT00458653 | Phase 1 | Apr 1, 2005 | Harvard University, Technion University |
| NCT00458536 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2004 | Harvard University, National Cancer Institute (NCI) |
| NCT00459069 | Phase 1 | Jul 1, 2004 | Harvard University |
| NCT00085397 | Phase 2 | Mar 1, 2004 | Harvard University, National Cancer Institute (NCI) |
| NCT00795977 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2003 | Fukushima Medical University |
| NCT00626860 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2000 | Genzyme, Harvard University |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 7 | 7 | 2 | 2000 |
| National Cancer Institute (NCI) | Government | 6 | 0 | 2 | 2004 |
| Blood and Marrow Transplant Clinical Trials Network | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Center for International Blood and Marrow Transplant Research | Government | 1 | 0 | 1 | 2016 |
| Department of Defense | Government | 1 | 0 | 1 | 2009 |
| Fukushima Medical University | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Genzyme | For profit | 1 | 0 | 1 | 2000 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2010 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 1 | 1 | 2016 |
| National Marrow Donor Program | Government | 1 | 0 | 1 | 2016 |
| Technion University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2017 |
12 organizations
Page 1 / 1